These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24032410)

  • 1. Features of modularly assembled compounds that impart bioactivity against an RNA target.
    Rzuczek SG; Gao Y; Tang ZZ; Thornton CA; Kodadek T; Disney MD
    ACS Chem Biol; 2013 Oct; 8(10):2312-21. PubMed ID: 24032410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1.
    Childs-Disney JL; Parkesh R; Nakamori M; Thornton CA; Disney MD
    ACS Chem Biol; 2012 Dec; 7(12):1984-93. PubMed ID: 23130637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.
    Childs-Disney JL; Hoskins J; Rzuczek SG; Thornton CA; Disney MD
    ACS Chem Biol; 2012 May; 7(5):856-62. PubMed ID: 22332923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.
    Angelbello AJ; González ÀL; Rzuczek SG; Disney MD
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5792-5796. PubMed ID: 27839685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrocyclization of a Ligand Targeting a Toxic RNA Dramatically Improves Potency.
    Benhamou RI; Vezina-Dawod S; Choudhary S; Won Wang K; Meyer SM; Yildirim I; Disney MD
    Chembiochem; 2020 Nov; 21(22):3229-3233. PubMed ID: 32649032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy.
    Lee MM; Childs-Disney JL; Pushechnikov A; French JM; Sobczak K; Thornton CA; Disney MD
    J Am Chem Soc; 2009 Dec; 131(47):17464-72. PubMed ID: 19904940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
    Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC
    J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of flexibility in the rational design of modularly assembled ligands targeting the RNAs that cause the myotonic dystrophies.
    Disney MD; Lee MM; Pushechnikov A; Childs-Disney JL
    Chembiochem; 2010 Feb; 11(3):375-82. PubMed ID: 20058255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
    Angelbello AJ; Rzuczek SG; Mckee KK; Chen JL; Olafson H; Cameron MD; Moss WN; Wang ET; Disney MD
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7799-7804. PubMed ID: 30926669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
    Rzuczek SG; Colgan LA; Nakai Y; Cameron MD; Furling D; Yasuda R; Disney MD
    Nat Chem Biol; 2017 Feb; 13(2):188-193. PubMed ID: 27941760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the Linker Domain in a Dimeric Compound that Degrades an r(CUG) Repeat Expansion in Cells.
    Benhamou RI; Abe M; Choudhary S; Meyer SM; Angelbello AJ; Disney MD
    J Med Chem; 2020 Jul; 63(14):7827-7839. PubMed ID: 32657583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.
    Childs-Disney JL; Stepniak-Konieczna E; Tran T; Yildirim I; Park H; Chen CZ; Hoskins J; Southall N; Marugan JJ; Patnaik S; Zheng W; Austin CP; Schatz GC; Sobczak K; Thornton CA; Disney MD
    Nat Commun; 2013; 4():2044. PubMed ID: 23806903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.
    Rzuczek SG; Southern MR; Disney MD
    ACS Chem Biol; 2015 Dec; 10(12):2706-15. PubMed ID: 26414664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
    Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
    PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.
    Jahromi AH; Nguyen L; Fu Y; Miller KA; Baranger AM; Zimmerman SC
    ACS Chem Biol; 2013 May; 8(5):1037-43. PubMed ID: 23480597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule alteration of RNA sequence in cells and animals.
    Guan L; Luo Y; Ja WW; Disney MD
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2794-2796. PubMed ID: 29079470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR structures of small molecules bound to a model of a CUG RNA repeat expansion.
    Chen JL; Taghavi A; Frank AJ; Fountain MA; Choudhary S; Roy S; Childs-Disney JL; Disney MD
    Bioorg Med Chem Lett; 2024 Oct; 111():129888. PubMed ID: 39002937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.